secwatch / observer
8-K filed August 9, 2023, 7:59 PM ET ticker SONM CIK 0001178697
leadership confidence high sentiment neutral materiality 0.35

Sonim board members Alan Howe and Jose Principe to retire; Howe to remain as consultant

DNA X, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Alan Howe

Director
SONM · DNA X, Inc.
Filed
August 9, 2023, 7:59 PM ET
On August 3, 2023, Alan Howe informed the board of directors (the “Board”) of Sonim Technologies, Inc. (the “Company”) of his decision to retire from, and not stand for re-election to the Board, effective as of the end of his term, the date of the conclusion of the Company’s 2023 annual meeting of stockholders.
Departed

Jose C. Principe

Director
SONM · DNA X, Inc.
Filed
August 9, 2023, 7:59 PM ET
On August 3, 2023, Jose C. Principe informed the Board of his decision to retire from, and not stand for re-election to the Board, effective as of the end of his term, the date of the conclusion of the Company’s 2023 annual meeting of stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Alan Howe retired as Director at DNA X, Inc..

Action
retired
Role
Director
Exact text from the filing
On August 3, 2023, Alan Howe informed the board of directors (the “Board”) of Sonim Technologies, Inc. (the “Company”) of his decision to retire from, and not stand for re-election to the Board, effective as of the end of his term, the date of the conclusion of the Company’s 2023 annual meeting of stockholders.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Jose C. Principe retired as Director at DNA X, Inc..

Action
retired
Role
Director
Exact text from the filing
On August 3, 2023, Jose C. Principe informed the Board of his decision to retire from, and not stand for re-election to the Board, effective as of the end of his term, the date of the conclusion of the Company’s 2023 annual meeting of stockholders.
View on SEC.gov

DNA X, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-23-027387
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.